NIH-funded research R01 grant

How bacteria change their DNA to survive antibiotics

Official title: Contribution of insertion sequence mediated tandem chromosomal amplification to bacterial heterogeneity

Funded at Pennsylvania State University, the · NIH-10872780 · Data updated 2026-11-12

This study is looking at how tiny pieces of DNA in bacteria can change their traits, helping them survive against antibiotics, and the findings could lead to better treatments for infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State University, the
NIH-funded
Lab location1 site (University Park, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$456,746
NIH project number1R01GM154193-01
Project IDNIH-10872780 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals suffering from bacterial infections, particularly those caused by antibiotic-resistant strains.

Less likely to help

Patients with viral infections or those not affected by bacterial resistance may not receive any benefit from this research.

What this research studies

This research investigates how certain DNA elements in bacteria can lead to variations within bacterial populations by amplifying segments of their chromosomes. By focusing on insertion sequences, which are mobile DNA elements, the research aims to understand how these sequences can create diverse bacterial traits that may help them survive antibiotic treatments. The study employs advanced genetic techniques to analyze the mechanisms behind this amplification and its effects on bacterial behavior. Patients may benefit from insights gained into bacterial resistance, potentially leading to more effective antibiotic therapies.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for combating antibiotic-resistant infections.

How similar studies have gone: Previous research has shown that understanding genetic mechanisms in bacteria can lead to breakthroughs in treating antibiotic resistance, indicating that this approach has potential for success.

Where this research is happening

  • Pennsylvania State University, the
    University Park, United States
    Active

Researchers

  • Principal investigator: Meredith, Timothy C. — Pennsylvania State University, the
  • Study coordinator: Meredith, Timothy C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.